Pitt develops potential vaccine for novel coronavirus
Researchers from the University of Pittsburgh School of Medicine have developed a potential vaccine administered by a fingertip-sized patch to neutralize the novel coronavirus SARS-CoV-2 that causes COVID-19.
A scientific paper about the vaccine candidate known as PittCoVacc — Pittsburgh Coronavirus Vaccine — is being published Thursday by EBioMedicine, which is part of the renowned British medical journal The Lancet. PittCoVacc has been tested already in mice by Pitt scientists and created…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Paul J. Gough Source Type: news
More News: Coronavirus | COVID-19 | Health Management | Pharmaceuticals | SARS | UK Health | Vaccines